Research into risk factors causing malignant neoplasms of the digestive organs in the Aral sea region of Uzbekistan: A case-control study

UDC: 
616-006.6: 614.2-036.22
DOI: 
10.21668/health.risk/2025.3.03.eng
Authors: 

N.V. Torchinskii, N.K. Dauletnazarov, Yu.E. Vyazovichenko

Organization: 

I.M. Sechenov First Moscow State Medical University (Sechenov University), 8 Trubetskaya Str., build. 2, Moscow, 119048, Russian Federation

Abstract: 

An alarming trend is observed in recent years involving growing incidence of malignant neoplasms of the gastrointestinal tract. It appears to be associated with a non-hereditary etiology. Behavioral factors, lifestyle, nutrition, microbes, the environment and physiological mechanisms of the host may all play a key role in this. This prompted us to study risk factors causing development of malignant neoplasms.

The aim of this study was to identify risk factors causing malignant neoplasms of the digestive organs in the Aral Sea region of Uzbekistan (the Republic of Karakalpakstan). These risk factors were established by conducting a case-control analytical epidemiological study involving 307 participants; of them, 151 were respondents with malignant neoplasms of the digestive system and 156 relatively healthy respondents. The study was conducted at the Karakalpakstan branch of the Republican Specialized Scientific and Practical Medical Centre for Oncology and Radiology of the Republic of Uzbekistan.

The results of the study have determined that the leading risk factors causing development of digestive cancer are bad habits such as alcohol consumption of 500 ml/week or more (OR = 2.09), smoking 10 or more cigarettes per day (OR = 2.61) and being a current smoker (OR = 2.72). Smoking nasvay, which is common in Central Asia, is also a significant risk factor for digestive cancer in men (OR = 3.587). Dietary habits also play an important role, particularly the consumption of 500 g or more of red meat per week, which creates elevated risks of developing cancer of the digestive organs (OR = 2.08). The physiological balance of the human body determines its health state. Thus, abdominal obesity (OR = 2.24) and a history of being overweight (OR = 2.69) increase the risk of developing malignant neoplasms of the digestive organs. Additionally, the odds ratio (OR) for individuals who prefer hot tea is 1.31 (95 % confidence interval (CI): 0.83–2.07). According to our findings, psycho-emotional states such as stress following the loss of a loved one (OR = 3.25), work involving stressful tasks (OR = 2.84), intense work (OR = 2.17), sleep disorders or insomnia in the last six months (OR = 2.20), and prolonged depression (OR = 2.12) increase the risk of developing digestive cancer.

All examined risk factors are manageable and each of them can be a target for primary prevention of malignant neoplasms of the digestive system.

Keywords: 
malignant neoplasms, digestive organs, epidemiology, risk factors, case-control study, prevention, oncology
Тorchinskii N.V., Dauletnazarov N.K., Vyazovichenko Yu.E. Research into risk factors causing malignant neoplasms of the digestive organs in the Aral Sea region of Uzbekistan: a case-control study. Health Risk Analysis, 2025, no. 3, pp. 24–31. DOI: 10.21668/health.risk/2025.3.03.eng
References: 
  1. Ben-Aharon I., van Laarhoven H.W.M., Fontana E., Obermannova R., Nilsson M., Lordick F. Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications. Cancer Discov., 2023, vol. 13, no. 3, pp. 538–551. DOI: 10.1158/2159-8290.CD-22-1038
  2. Lutgendorf S.K., Sood A.K. Biobehavioral Factors and Cancer Progression: Physiological Pathways and Mechanisms. Psychosom. Med., 2011, vol. 73, no. 9, pp. 724–730. DOI: 10.1097/PSY.0b013e318235be76
  3. Rumgay H., Shield K., Charvat H., Ferrari P., Sornpaisarn B., Obot I., Islami F., Lemmens V.E.P.P. [et al.]. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol., 2021, vol. 22, no. 8, pp. 1071–1080. DOI: 10.1016/S1470-2045(21)00279-5
  4. Critchley J.A., Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax, 2003, vol. 58, no. 5, pp. 435–443. DOI: 10.1136/thorax.58.5.435
  5. Fan Y., Yuan J.-M., Wang R., Gao Y.-T., Yu M.C. Alcohol, Tobacco, and Diet in Relation to Esophageal Cancer: The Shanghai Cohort Study. Nutr. Cancer., 2008, vol. 60, no. 3, pp. 354–363. DOI: 10.1080/01635580701883011
  6. Gandini S., Botteri E., Iodice S., Boniol M., Lowenfels A.B., Maisonneuve P., Boyle P. Tobacco smoking and cancer: A meta‐analysis. Int. J. Cancer, 2008, vol. 122, no. 1, pp. 155–164. DOI: 10.1002/ijc.23033
  7. Ye F., Zhang G.-H., Guan B.-X., Xu X.-C. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J. Gastroenterol., 2012, vol. 18, no. 2, pp. 126–135. DOI: 10.3748/wjg.v18.i2.126
  8. Liu L., Hou L., Gu S., Zuo X., Meng D., Luo M., Zhang X., Huang S., Zhao X. Molecular mechanism of epigallocate-chin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. Oncol. Rep., 2015, vol. 33, no. 1, pp. 297–303. DOI: 10.3892/or.2014.3555
  9. Chen Y.-K., Lee C.-H., Wu I.-C., Liu J.-S., Wu D.-C., Lee J.-M., Goan Y.-G., Chou S.-H. [et al.]. Food intake and the occurrence of squamous cell carcinoma in different sections of the esophagus in Taiwanese men. Nutrition, 2009, vol. 25, no. 7–8, pp. 753–761. DOI: 10.1016/j.nut.2009.02.002
  10. Nechuta S., Shu X.-O., Li H.-L., Yang G., Ji B.-T., Xiang Y.-B., Cai H., Chow W.-H. [et al.]. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women’s Health Study. Am. J. Clin. Nutr., 2012, vol. 96, no. 5, pp. 1056–1063. DOI: 10.3945/ajcn.111.031419
  11. Sang L.-X., Chang B., Li X.-H., Jiang M. Green Tea Consumption and Risk of Esophageal Cancer: A Meta-Analysis of Published Epidemiological Studies. Nutr. Cancer, 2013, vol. 65, no. 6, pp. 802–812. DOI: 10.1080/01635581.2013.805423
  12. Zheng J.-S., Yang J., Fu Y.-Q., Huang T., Huang Y.-J., Li D. Effects of Green Tea, Black Tea, and Coffee Consump-tion on the Risk of Esophageal Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Nutr. Cancer, 2013, vol. 65, no. 1, pp. 1–16. DOI: 10.1080/01635581.2013.741762
  13. Zheng P., Zheng H.-M., Deng X.-M., Zhang Y. Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies. BMC Gastroenterol., 2012, vol. 12, pp. 165. DOI: 10.1186/1471-230X-12-165
  14. Sung H., Siegel R.L., Torre L.A., Pearson-Stuttard J., Islami F., Fedewa S.A., Sauer A.G., Shuval K. [et al.]. Global patterns in excess body weight and the associated cancer burden. CA A Cancer J. Clin., 2019, vol. 69, no. 2, pp. 88–112. DOI: 10.3322/caac.21499
  15. Du X., Hidayat K., Shi B.-M. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies. Biosci. Rep., 2017, vol. 37, no. 3, pp. BSR20160474. DOI: 10.1042/BSR20160474
  16. Dong Y., Zhou J., Zhu Y., Luo L., He T., Hu H., Liu H., Zhang Y. [et al.]. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies. Biosci. Rep., 2017, vol. 37, no. 6, pp. BSR20170945. DOI: 10.1042/BSR20170945
  17. Aune D., Greenwood D.C., Chan D.S.M., Vieira R., Vieira A.R., Navarro Rosenblatt D.A., Cade J.E., Burley V.J., Norat T. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studies. Ann. Oncol., 2012, vol. 23, no. 4, pp. 843–852. DOI: 10.1093/annonc/mdr398
  18. Rahmani J., Varkaneh H.K., Kontogiannis V., Ryan P.M., Bawadi H., Fatahi S., Zhang Y. Waist Circumference and Risk of Liver Cancer: A Systematic Review and Meta-Analysis of over 2 Million Cohort Study Participants. Liver Cancer, 2020, vol. 9, no. 1, pp. 6–14. DOI: 10.1159/000502478
  19. Alford S., Patel D., Perakakis N., Mantzoros C.S. Obesity as a risk factor for Alzheimer’s disease: weighing the evi-dence. Obes. Rev., 2018, vol. 19, no. 2, pp. 269–280. DOI: 10.1111/obr.12629
  20. Upadhyay J., Farr O., Perakakis N., Ghaly W., Mantzoros C. Obesity as a Disease. Med. Clin. North Am., 2018, vol. 102, no. 1, pp. 13–33. DOI: 10.1016/j.mcna.2017.08.004
  21. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Choice Reviews Online, 2008, vol. 45, no. 09, pp. 45-5024-45–5024.
  22. Farvid M.S., Sidahmed E., Spence N.D., Angua K.M., Rosner B.A., Barnett J.B. Consumption of red meat and pro-cessed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. Eur. J. Epidemiol., 2021, vol. 36, no. 9, pp. 937–951. DOI: 10.1007/s10654-021-00741-9
  23. Bose M., Oliván B., Laferrère B. Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease. Curr. Opin. Endocrinol. Diabetes Obes., 2009, vol. 16, no. 5, pp. 340–346. DOI: 10.1097/MED.0b013e32832fa137
  24. Kruk J., Hassan Aboul-Enein B., Bernstein J., Gronostaj M. Psychological Stress and Cellular Aging in Cancer: A Meta-Analysis. Oxid. Med. Cell. Longev., 2019, vol. 2019, pp. 1270397.
  25. Spiegel D., Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol. Psychiatry, 2003, vol. 54, no. 3, pp. 269–282. DOI: 10.1016/s0006-3223(03)00566-3
  26. Kabiri N., Khodayari-Zarnaq R., Khoshbaten M., Janati A. Gastrointestinal Cancer Prevention Policies: A Qualitative Systematic Review and Meta-Synthesis. Int. J. Prev. Med., 2022, vol. 13, pp. 8. DOI: 10.4103/ijpvm.IJPVM_419_20
Received: 
20.06.2025
Approved: 
10.09.2025
Accepted for publication: 
28.09.2025

You are here

Home